← Eichor
Study identifier: NCT06421740 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

Condition: Atopic Dermatitis  ·  Sponsor: AbbVie

PhaseN/A
Planned participants1000
Who can joinAll sexes, 12 Years to no upper limit
Healthy volunteersNo

About this study

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Upadacitinib is an approved drug for treating AD. Approximately 1000 adolescents and adult participants who are prescribed upadacitinib by their physician in accordance with local label will be enrolled in up to 40 sites in China. Participants will receive oral upadacitinib tablets as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed up for approximately 12 months. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Judy Yu  ·  wenjun.yu@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (38)

Beijing Anzhen Hospital /ID# 273443Beijing, Beijing Municipality, ChinaActive Not Recruiting
China-Japan Friendship Hospital /ID# 274778Beijing, Beijing Municipality, ChinaActive Not Recruiting
Peking University First Hospital /ID# 274865Beijing, Beijing Municipality, ChinaActive Not Recruiting
Peking Unversity Third hospital /ID# 274864Beijing, Beijing Municipality, ChinaActive Not Recruiting
Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 264193Beijing, Beijing Municipality, ChinaActive Not Recruiting
The First Affiliated Hospital Of Fujian Medical University /ID# 268210Fuzhou, Fujian, ChinaActive Not Recruiting
Changgeng Hospital /ID# 268209Xiamen, Fujian, ChinaActive Not Recruiting
Guangzhou Dermatology Hospital /ID# 271684Guangzhou, Guangdong, ChinaActive Not Recruiting
The Fifth Affiliated Hospital Of Sun Yat-Sen University /ID# 268618Zhuhai, Guangdong, ChinaActive Not Recruiting
Hainan Fifth People's Hospital /ID# 269747Hainan, Hainan, ChinaActive Not Recruiting
Hebei Engineering University Affiliated Hospital /ID# 268660Handan, Hebei, ChinaActive Not Recruiting
The Second Affiliated Hospital Of Harbin Medical University /ID# 270872Harbin, Heilongjiang, ChinaActive Not Recruiting

+ 26 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06421740